Risk factors for osteoporosis

References

• Bohannon AD. Osteoporosis and African American women. J Womens Health Gend Based Med 1999;8:609–15
   PubMedGoogle Scholar
• Barrett JA, Baron JA, Karagas MR, Beach ML. Fracture risk in the US Medicare population. J Clin Epidemiol 1999;52:243–9
   PubMed Web of Science ®Google Scholar
• Kotzan JA, Martin BC, Reeves JH, Wade W. The impact of race and fractures on mortality in a postmenopausal Medicaid population. Clin Ther 1999;21:1988–2000
   PubMed Web of Science ®Google Scholar
• Kellie SE, Brody JA. Sex-specific and race-specific hip fracture rates. Am J Public Health 1990;80:326–8
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9: 1137–41
   PubMed Web of Science ®Google Scholar
• Lenchik L, Leib ES, Hamdy RC, Binkley NC, Miller PD, Watts NB. Executive summary. International Society for Clinical Densitometry position development conference. Denver, Colorado July 20–22, 2001. J Clin Densitom 2002;5(Suppl): S1–3
   Google Scholar
• National Osteoporosis Foundation. Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation, 2003
   Google Scholar
• Bohannon AD, Hanlon JT, Landerman R, Gold DT. Association of race and other potential risk factors with nonvertebral fractures in community-dwelling elderly women. Am J Epidemiol 1999;149:1002–9
   PubMed Web of Science ®Google Scholar
• Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group. N Engl J Med 1994;330:1555–9
   PubMed Web of Science ®Google Scholar
• Kritz-Silverstein D, Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health 1993;83:100–2
   PubMed Web of Science ®Google Scholar
• Lindsay R, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986;34:333–40
   Google Scholar
• Tuppurainen M, Kroger H, Saarikoski S, Honkanen R, Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int 1994;4:93–8
   Google Scholar
• Nelson H, Helfand M. Hormone replacement therapy and osteoporosis. Systematic evidence review Number 12. Rockville, MD. Available at: http://www.ahrq.gov/clinic/serfiles.htm. Accessed June 03, 2003
   Google Scholar
• Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI. JAMA 1996;276:1389–96
   PubMed Web of Science ®Google Scholar
• Ravn P, Bidstrup M, Wasnich RD, et al. Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Intern Med 1999;131:935–42
   PubMed Web of Science ®Google Scholar
• Recker RR, Davies KM, Dowd RM, Heaney RP. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Ann Intern Med 1999;130:897–904
   PubMed Web of Science ®Google Scholar
• Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Amin S. Osteoarthritis and bone mineral density: what is the relation and why does it matter? J Rheumatol 2002;29:1348–9
   PubMed Web of Science ®Google Scholar
• Miyakoshi N, Itoi E, Murai H, Wakabayashi I, Ito H, Minato T. Inverse relation between osteoporosis and spondylosis in postmenopausal women as evaluated by bone mineral density and semiquantitative scoring of spinal degeneration. Spine 2003;28:492–5
   PubMed Web of Science ®Google Scholar
• Looker AC, Orwoll ES, Johnston Jr. CC, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 1997;12:1761–8
   Google Scholar
• Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001;286: 2815–22
   Google Scholar
• Orwig DL, Brandt N, Zimmerman G, Smith A. Bone-strengthening medication use and low bone density in black elderly women. J Bone Min Res 2002;17:S259
   Google Scholar